|Bid||0.00 x 1200|
|Ask||0.00 x 900|
|Day's Range||158.18 - 159.99|
|52 Week Range||112.03 - 178.10|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||13.92%|
|Beta (5Y Monthly)||0.86|
|Expense Ratio (net)||0.35%|
GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...
Yahoo Finance's Seana Smith and ETF Trends CIO and Director Dave Nadig discuss the outlook on biotech ETFs as optimism grows over results for coronavirus treatments.
Biotech ETFs are among the most popular investment vehicles. Here are some reasons for why they're worth considering.